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ABSTRACT
Splice-switching oligonucleotides (SSOs) have been
widely used to inhibit exon usage but antisense
strategies that promote removal of entire introns
to increase splicing-mediated gene expression have
not been developed. Here we show reduction of INS
intron 1 retention by SSOs that bind transcripts de-
rived from a human haplotype expressing low lev-
els of proinsulin. This haplotype is tagged by a
polypyrimidine tract variant rs689 that decreases the
efficiency of intron 1 splicing and increases the rela-
tive abundance of mRNAs with extended 5′ untrans-
lated region (5′UTR), which curtails translation. Co-
expression of haplotype-specific reporter constructs
with SSOs bound to splicing regulatory motifs and
decoy splice sites in primary transcripts revealed a
motif that significantly reduced intron 1-containing
mRNAs. Using an antisense microwalk at a single nu-
cleotide resolution, the optimal target was mapped to
a splicing silencer containing two pseudoacceptor
sites sandwiched between predicted RNA guanine
(G) quadruplex structures. Circular dichroism spec-
troscopy and nuclear magnetic resonance of syn-
thetic G-rich oligoribonucleotide tracts derived from
this region showed formation of a stable parallel 2-
quartet G-quadruplex on the 3′ side of the antisense
retention target and an equilibrium between quadru-
plexes and stable hairpin-loop structures bound by
optimal SSOs. This region interacts with heteroge-
neous nuclear ribonucleoproteins F and H that may
interfere with conformational transitions involving
the antisense target. The SSO-assisted promotion of
weak intron removal from the 5′UTR through compet-
ing noncanonical and canonical RNA structures may
facilitate development of novel strategies to enhance
gene expression.
INTRODUCTION
Most eukaryotic genes contain intervening sequences or in-
trons that must be accurately removed from primary tran-
scripts to create functional mRNAs capable of encoding
proteins (1). This process modifies mRNP composition in
a highly dynamic manner, employing interdependent inter-
actions of five small nuclear RNAs and a large number of
proteins with conserved but degenerate sequences in the
pre-mRNA (2). Intron splicing generally promotes mRNA
accumulation and protein expression across species (3–5).
This process can be altered by intronic mutations or vari-
ants that may also impair coupled gene expression path-
ways, including transcription, mRNA export and transla-
tion. This is best exemplified by introns in the 5′ untrans-
lated region (5′UTR) where natural variants or mutations
modifying intron retention alter the relative abundance of
transcripts with upstream open reading frames (uORFs) or
other regulatory motifs and dramatically influence transla-
tion (6,7). However, successful sequence-specific strategies
to normalize gene expression in such situations have not
been developed.
Splice-switching oligonucleotides (SSOs) are antisense
reagents that modulate intron splicing by binding splice-site
recognition or regulatory sequences and competing with
cis- and trans-acting factors for their targets (8). They have
been shown to restore aberrant splicing, modify the rela-
tive expression of existing mRNAs or produce novel splice
variants that are not normally expressed (8). Improved sta-
bility of targeted SSO-RNA duplexes by a number of SSO
modifications, such as 2′-O-methyl and 2′-O-methoxyethyl
ribose, facilitated studies exploring their therapeutic poten-
tial for a growing number of human disease genes, including
DMD in muscular dystrophy (9,10), SMN2 in spinal mus-
cular atrophy (11), ATM in ataxia-telangiectasia (12) and
BTK in X-linked agammaglobulinemia (13). Although such
approaches are close to achieving their clinical potential for
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a restricted number of diseases (8), >300 Mendelian disor-
ders resulting frommutation-induced aberrant splicing (14)
and a growing number of complex traits may be amenable
to SSO-mediated correction of gene expression.
Etiology of type 1 diabetes has a strong genetic compo-
nent conferred by human leukocyte antigens (HLA) and
a number of modifying non-HLA loci (15). The strongest
modifier was identified in the proinsulin gene (INS) re-
gion on chromosome 11 (termed IDDM2) (15). Further
mapping of this area suggested that INS is the most likely
IDDM2 target (16), consistent with a critical role of this au-
toantigen in pathogenesis (17). Genetic risk to this disease
at IDDM2 has been attributed to differential steady-state
RNA levels from predisposing and protective INS haplo-
types, potentially involving a minisatellite DNA sequence
upstream of this gene (18,19). However, systematic exami-
nation of naturally occurring INS polymorphisms revealed
haplotype-specific proinsulin expression levels in reporter
constructs devoid of the minisatellite sequence, resulting
from two variants in intron 1 (7), termed IVS1+5ins4 (also
known as rs3842740 or INS-69) and IVS1–6A/T (rs689,
INS-27 or HphI+/−) (16,20). The former variant activates
a cryptic 5′ splice site of intron 1 whereas adenine (A) at
the latter variant, which resides 6 nucleotides upstream of
the 3′ splice site (3′ss), promotes intron retention, expanding
the relative abundance of transcripts with extended 5′UTR
(21). As compared to thymine (T), the A allele at IVS1–
6A/T decreases affinity to pyrimidine-binding proteins in
vitro and renders the 3′ss more dependent on the auxiliary
factor of U2 small nuclear ribonucleoprotein (U2AF) (7), a
heterodimer required forU2 binding, spliceosome assembly
and 3′ss selection (22). Intron 1-containing transcripts are
overrepresented in IVS1-6A-derived cDNA libraries pre-
pared from insulin producing tissues (21), are exported from
the nucleus (23) and contain a short, Homininae-specific
uORF that co-evolved with relaxation of the 3′ss of intron
1 in higher primates (7). The lower proinsulin expression
conferred by the A allele may lead to suboptimal presenta-
tion of proinsulin peptides in the foetal thymus and inade-
quate negative selection of autoreactive T cells, culminating
in autoimmune destruction of insulin-producing  cells in
the pancreas (7). However, no attempts have been made to
correct the low efficiency of INS intron 1 removal from the
IVS1-6A-containing pre-mRNAs and reduce intron reten-
tion to the levels observed for the disease-protective T allele.
In this study, we set out to search for SSOs that increase
the efficiency of INS intron 1 splicing and repress splicing
silencers or decoy splice sites in the pre-mRNA to enhance
proinsulin expression. We report identification of SSOs re-
ducing the relative abundance of intron 1-retaining tran-
scripts, delineation of the optimized antisense target at a
single-nucleotide resolution, evidence for formation of a
parallel G-quadruplex adjacent to the antisense target se-
quence and identification of proteins that bind to this re-
gion.
MATERIALS AND METHODS
Antisense oligonucleotides
SSOs were purchased from the MWG Biotech (Germany).
All SSOs and scrambled controls had a full-length phos-
Figure 1. Location of SSOs in the human proinsulin gene. (A) Schematics
of the INS reporter and its mRNA products. SSOs are shown as black
horizontal bars below exons (numbered boxes) and below intron 1 (line);
their sequences are in Supplementary Table S1. Start and stop codons are
denoted by arrowheads. Canonical (solid lines) and cryptic (dotted lines)
splicing is shown above the primary transcript; designation of cryptic splice
sites is in grey. SSOs targeting intron 1 segments del4-del7 are shown in the
lower panel. (B) mRNA isoforms (numbered 1–6) generated by the INS
reporter construct. Description of isoforms that do not produce proinsulin
is in grey.
phorothioate backbone with 2′-O-methyl ribonucleotides at
the second ribose position. Apart from INS SSOs and their
scrambled versions, we employed SSOs that target other hu-
man genes as additional controls, as described (13). Loca-
tion of each SSO is shown in Figure 1A and their sequences
in Supplementary Table S1.
Splicing reporter constructs
The wild-type splicing reporter carrying the type 1 diabetes-
associated haplotype termed IC was reported previ-
ously (7,21). Each construct contains all INS exons and
unabridged introns but differ in the length of the last exon.
The IC reporters were cloned using primers D-C, D-F and
D-B; IC D-B lacks the cryptic 3′ss of intron 2. The relative
abundance of isoforms spliced to this site is lower for IC D-
F than for IC D-C (7,21). To test SSOs targeting the cryptic
5′ splice site of intron 1, the IC construct was modified by a
4-nt insertion at rs3842740 to create a reporter termed IC-
IVS1+5ins4. TSC2 and F9 constructs were reported previ-
ously (24). Plasmids were propagated in the E. coli strain
DH5 and plasmid DNA was extracted using the Wizard
Plus SV Miniprep kit (Promega, USA). Their inserts were
completely sequenced to confirm the identity of each of the
14 intragenic natural variants and to exclude undesired mu-
tations.
 at U
niversity of Southam
pton on M
ay 12, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
Nucleic Acids Research, 2014, Vol. 42, No. 12 8163
Cell cultures and transfections
Human embryonic kidney 293 (HEK293), human hepato-
cellular liver carcinoma HepG2 and African green mon-
key COS7 cells were cultured in Dulbecco’s modified Eagle
medium, 10% fetal calf serum and penicillin/streptomycin
(Life technologies, USA). Transient transfections were car-
ried out as described (13), using jetPRIME (Polyplus, USA)
according to manufacturer’s recommendations. Downregu-
lation of U2AF35 by RNA interference (RNAi) to induce
cryptic 3′ss of intron 1 was performed with two hits of small
interfering RNA (siRNA) U2AF35ab, as reported earlier
(7,25); siRNA duplex targeting DHX36 was as described
(26). The second hit was applied 24 h before the addition
of SSOs and/or reporter. Cell cultures were harvested 24 h
after addition of reporter constructs.
Analysis of spliced products
Total RNA was extracted with TRI Reagent and treated
with DNase (Life technologies, USA). The first-strand
cDNA was reverse transcribed using oligo-(dT)15 primers
and Moloney murine virus reverse transcriptase (Promega,
USA). Polymerase chain reaction (PCR) was carried out
with a combination of a vector-specific primer PL3 and
primer E targeting the 3′UTR, as reported previously (7).
PCR products were separated on polyacrylamide gels and
their signal intensity was measured as described (27). The
identity of each mRNA isoform was confirmed by Sanger
nucleotide sequencing.
Circular dichroism and nuclear magnetic resonance spec-
troscopy
Oligoribonucleotides for circular dichroism (CD) and nu-
clear magnetic resonance (NMR) were purchased from
Thermo Scientific, deprotected according tomanufacturer’s
instructions, lyophilized and stored at −20◦C. Stock solu-
tions were prepared from the desalted, lyophilized samples
by resuspending in milliQ water or KCl buffer (100 mM
KCl, 10 mMK2HPO4/KH2PO4, pH 7.0, milliQ water) to a
final concentration of 2–4 M.
CD spectra were acquired using a PiStar-180 spectropho-
tometer (Applied Photophysics Ltd, Surrey, UK), equipped
with a LTD6G circulating water bath (Grant Instruments,
UK) and thermoelectric temperature controller (Melcor,
USA). Samples were heated in the cell to 95oC for a total
period of 15 min, samples were then annealed by allowing
to cool to room temperature for a minimum period of 4 h.
CD spectra were recorded over a wavelength range of 215–
340 nm using a 1 cm path length strain-free quartz cuvette
and at the temperatures indicated. Data points recorded
at 1 nm intervals. A bandwidth of 3 nm was used and
5000 counts acquired at each point with adaptive sampling
enabled. Each trace is shown as the mean of three scans
(±SD). CD temperature ramps were acquired at 265 nm
corresponding to the band maxima of the folded quadru-
plex species. Ranges between 5 and 99oC were used, with
points acquired at 0.5oC intervals with a 120–180 s time-
step between 0.5oC increments. Points were acquired with
10 000 counts and adaptive sampling enabled. Heating and
cooling studies were compared to check for hysteresis and
overall reversibility.
NMR spectra (1H) were collected at 800 MHz using a
Bruker Avance III spectrometer with a triple resonance cry-
oprobe. Standard Bruker acquisition parameters were used.
Data were collected using Topspin (v. 3.0) and processed in
CCPN Analysis (v. 2.1).
Pull-down assays and western blotting
In vitro transcription was carried out using
MEGAshortscriptTM T7 (LifeTechnologies, USA) and
T7-tagged PCR products amplified with primers 5′-
ATTAATACGACTCACTATAGGGCTCAGGGTTCC
AGG and 5′-TGCAGCAGGGAGGACG, and DNA of
the indicated plasmids as a template. Indicated synthetic
RNAs were purchased from Eurofins UK. Five hundred
pmols of each RNA was treated with 5 mM sodium
m-periodate and bound to adipic acid dihydrazide agarose
beads (Sigma, USA). Beads with bound RNAs were
washed three times in 2 ml of 2 M NaCl and three times in
buffer D (20 mM HEPES–KOH, pH 7, 6.5% v/v glycerol,
100 m M KCl, 0.2 mM EDTA, 0.5 mM dithiothreitol),
incubated with HeLa nuclear extracts and buffer D with
heparin at a final concentration of 0.5 mg/ml. Unbound
proteins were washed five times with buffer D. Bound
proteins were separated on 10% sodium dodecyl sulphate-
polyacrylamide gel electrophoresis, stained by Coomassie
blue and/or blotted on to nitrocellulose membranes.
Western blotting was carried out as described (7). Anti-
bodies were purchased from Sigma (hnRNP E1/E2, prod-
uct number R4155, U2AF65, product number U4758 and
SFRS2, product number S2320), Abcam (DHX36, product
number ab70269) and Millipore (SC35, clone 1SC-4F11).
Antiserum against hnRNP F and hnRNP H was a gener-
ous gift of Prof. Douglas Black, UCLA.
Mass spectrometry analysis
Following trypsin digestion, samples were freeze dried and
resuspended with 25 ul of 5% ACN/0.1% formic acid
for mass spectrometry (MS). Peptides were analysed by
LC/MS/MS using a Surveyor LC system and LCQ Deca
XP Plus (ThermoScientific). The raw data files were con-
verted into mascot generic files using the MassMatrix File
Conversion Tool (Version 2.0; http://www.massmatrix.net)
for input into the Mascot searching algorithm (Matrix Sci-
ence).
Enzymatic structural probing
RNA secondary structure determination with the use of
limited V1 RNAse (Ambion), T1 RNAse (Ambion) and S1
nuclease (Fermentas) digestion has been described in detail
elsewhere (28). Briefly, 1 g aliquots of RNAs from the in-
sertion (ins) and deletion (del) pre-mRNAs were digested
with 0.002 U of RNAse V1, 0.05 U of RNAse T1 and 19 U
of S1 nuclease in a 100 l at 30◦C for 10 min. An enzyme-
free aliquot was used as a control (C). The cleaved RNAs
were retrotranscribed according to standard protocols us-
ing antisense primers labeled with [32P]-ATP at the 5′ end.
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RESULTS
Antisense oligonucleotides that promote pre-mRNA splicing
of a weak intron in 5′UTR
To identify SSOs capable of reducing retention of INS
intron 1 and increase splicing-mediated translational en-
hancement, we designed a series of 2′-O-methyl-modifed
phosphorothioate SSOs, individually co-expressed each
SSO with a splicing reporter construct carrying haplotype
IC in HEK293 cells and examined the relative abundance
of exogenous mRNA products (Figure 1A and B). The IC
haplotype in the reporter was devoid of the minisatellite se-
quence and contained a total of 14 polymorphic sites (7,20),
including the A allele at rs689. This allele inhibits intron
1 splicing and yields lower proinsulin levels as compared
to the more common T allele (21). SSOs targeting intron
1 and exon 2 were chosen in regions that showed the most
prominent alterations of exon inclusion or intron retention
in previous systematic deletion analyses of these sequences
(7). SSOs in exon 3 were located between authentic 3′ss of
intron 2 and a strong competing cryptic 3′ss 126 nt down-
stream to identify pre-mRNA motifs that modify their us-
age (Figure 1A).
Of the initial set of 15 INS SSOs tested in HEK293 cells,
11 showed reproducible alterations in the relative abun-
dance of mRNA isoforms (Supplementary Table S1). In-
tron 1 retentionwas significantly reduced by a single oligori-
bonucleotide SSO21 (P < 0.01, Mann-Whitney rank sum
test; Figure 2A). SSO21 targeted intron 1 positions 59–74,
encompassing a motif (termed del5) previously found to
confer the largest reduction of intron retention upon dele-
tion (7). The decrease in intron retention levels induced
by SSO21 was dose-dependent (Figure 2A) and was also
observed in HepG2 cells (Supplementary Figure S1) and
Chlorocebus aethiops COS7 cells (data not shown), consis-
tent with ubiquitous expression and a high degree of evolu-
tionary conservation of spliceosome components that em-
ploy auxiliary splicing sequences (1,2).
In addition to reducing intron 1 retention, SSO21 pro-
moted cryptic 3′ss of intron 2 (Figure 2A). However, this
effect was also seen for other INS SSOs and for scrambled
controls (Figure 3 and Supplementary Table S1), suggest-
ing non-specific interactions. To confirm that the SSO21-
induced enhancement of intron 1 splicing is not facilitated
by the cryptic 3′ss of intron 2, we cotransfected this SSO
with a shorter reporter lacking this site and retaining only
the first 89 nucleotides of exon 3. Figure 2B shows that
SSO21 was capable of promoting intron 1 splicing to the
same extent as the reporter with longer exon 3. In contrast,
the SSO21-induced decrease of intron retention was not ob-
served for the reporter lacking the del5 segment (data not
shown).
Apart from intron retention, we observed an increase of
exon 2 skipping for five SSOs, including SSO8 that bound
downstream of the cryptic 3′ss of intron 1 (cr3′ss+81; Fig-
ures 1 and 3C, Supplementary Table S1). This cryptic 3′ss
was induced by RNAi-mediated depletion of the small sub-
unit of U2AF (U2AF35) and was not reversed by a bridg-
ing oligoribonucleotide (SSO4) in cells lackingU2AF35; in-
stead we observed exon 2 skipping (Figure 3C). Depletion
Figure 2. SSO-induced inhibition of INS intron 1 retention. (A) Cotrans-
fection of the INS reporter construct (ICD-F)with the indicated SSOs into
HEK293 cells. Spliced products described in Figure 1B are shown to the
right. Bars represent percentage of intron 1-containing isoforms relative
to natural transcripts (upper panel) or percentage of splicing to the cryptic
3′splice site of intron 2 relative to the total (lower panel). Error bars denote
SD; sc, scrambled control; SSO-, ‘no SSO’ control. Final concentration of
SSOs was 1, 3, 10 and 30 nM, except for SSO6 and SSO8 (10 and 30 nM).
(B) SSO21-mediated promotion of intron 1 splicing in clones lacking the
cryptic 3′ss of intron 2. RNA products are to the right. (C) A fold change
in SSO21-induced intron 1 retention in transcripts containing and lacking
the cryptic 3′ss of intron 2. The final concentration of SSO21 was 30 nM
in duplicate transfection. Designation of the reporter constructs is at the
bottom.
of U2AF35 also repressed the cryptic 3′ss of intron 2. Taken
together, we identified a single SSO that reduced INS in-
tron 1 retention in several primate cell lines, consistent with
a high degree of evolutionary conservation of spliceosome
components that recognize auxiliary splicing sequences.
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Figure 3. INS SSOs targeting cryptic 3′ splice sites. (A) Activation of cryp-
tic 3′ss of intron 2 (cr3′ss+126; Figure 1A) by SSO6 and promotion of exon
2 skipping by SSO8. Concentration of each SSOwas 2, 10, 50 and 250 nM.
SSOs are shown at the top, spliced products to the right, reporter at the
bottom. (B) A predicted stable hairpin between the authentic and cryptic
3′ss of INS intron 2. Bases targeted by SSO6 are denoted by asterisks and
predicted splicing enhancer hexamers (listed to the right) are denoted by
a dotted line. (C) SSO4 does not prevent activation of cryptic 3′ss 81 base
pairs downstream of its authentic counterpart (cr3′ss+81) in cells depleted
of U2AF35 but induces exon skipping. The final concentration of each
SSO in COS7 cells was 5, 20 and 80 nM. The final concentration of the
siRNA duplex U2AF35ab (29) was 70 nM. The reporter was the same as
in panel A.
Optimization of the intron retention target at the single-
nucleotide level
Interestingly, other SSOs designed to target the del5 seg-
ment did not reduce intron 1 retention, except for a small
effect of SSO20 (Figures 1A and 2A). To test the impor-
tance of nucleotides flanking SSO21 and to map the op-
timal target at a single-base resolution, we carried out a
detailed antisense microwalk in this region. We individu-
ally co-transfected the INS reporter with additional eigh-
teen 16-mers bound 1–9 nucleotides 5′ and 3′ of SSO21 into
HEK293 cells and examined their RNA products. Intron 1
retention was most repressed by SSO21 and by SSOs that
were shifted by 1–2 nucleotides in each direction (Figure 4).
In agreement with the initial screen, SSOs targeting more
than one cytosine in the upstream run of four Cs (C4, see
SSO1 and SSO2, Figure 1A) were not effective (SSO21–3r
through SSO21–10r, Figure 4). In the opposite direction,
SSOs targeting consecutive Gs, which are often found in
intronic splicing enhancers (30–32), increased intron reten-
tion. Thus, the optimal antisense target for reducing reten-
tion of INS intron 1 was mapped at a single nucleotide res-
olution to a region previously identified as the most repres-
sive by a systematic deletion analysis of the entire intron (7).
Antisense target for intron retention is adjacent to a parallel
RNA quadruplex
We noticed that the target was sandwiched between two
intronic segments predicted to form stable RNA guanine
(G) quadruplexes (intron 1 nucleotides 36–61 and 78–93;
highlighted in Figure 4A). These structures are produced
by stacking G-quartets that consist of four Gs organized
in a cyclic Hoogsteen hydrogen bonding arrangement (33)
and have been implicated in important cellular processes,
including replication, recombination, transcription, trans-
lation (34,35) and RNA processing (36–40). To test if they
are formed in vitro, we employed synthetic ribonucleotides
derived from this region in CD spectroscopy that has been
used widely to characterize DNA and RNA quadruplex
structures (41–44). The CD spectrum of a downstream 19-
mer (termed CD1) recorded between 215 and 330 nm at
25◦C revealed strong positive ellipticity at 265 nm with
negative intensity at around 240 nm, indicative of a par-
allel quadruplex (Figure 5A). To confirm the presence of
a quadruplex, rather than other stable secondary struc-
ture motifs, we recorded UV absorbance spectra at 5◦C
and 95◦C. The UV absorbance difference spectrum at the
two temperatures (below and above the melting transition
point) showed the characteristic hyperchromic shift at∼295
nm (data not shown) and a double maximum at 240 nm
and 280 nm, providing evidence for formation of a sta-
ble parallel-stranded RNA quadruplex in vitro. This was
confirmed by 1H NMR studies of CD1 (Figure 5B) which
showed a characteristic envelope of signals between 10 and
12 ppm corresponding to Hoogsteen H-bonded Gs within
G-tetrad structures. Thermal stabilitymeasurements byCD
produced a highly reversible sigmoidal co-operative unfold-
ing transition with a Tm = 56.8 ± 0.2◦C (Figure 5C). Fig-
ure 5D (upper panel) shows a possible arrangement of the
19-mer into two stacked G-tetrads connected by relatively
short loop sequences of 1–4 nucleotides.
Conformational transition model for splicing inhibitory se-
quences in INS intron 1
CD of a synthetic 20-mer derived from a region upstream
of the antisense target (termed CD2) also showed evidence
of stable structure formation, giving a broader absorp-
tion envelope centered around 270 nm and a sigmoidal
thermal unfolding transition (Tm = 69.0 ± 0.45◦C; Fig-
ure 5A). Unlike the downstream oligo CD1, no hyper-
chromic shift in the UV was found in the thermal differ-
ence spectrum (data not shown). However, a well-defined
set of sharp signals in the 1H NMR spectrum between 12
and 14 ppm that differed from those for CD1 showed the
formation of Watson–Crick H-bonded base pairs charac-
teristic of double-stranded RNA (Figure 5B). Secondary
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Figure 4. Optimization of the intron retention target by antisense microwalk at a single-nucleotide resolution. (A) Location of oligoribonucletoides. Mi-
crowalk SSOs and oligos used for CD/NMR are represented by horizontal black bars below and above the primary transcript, respectively. Intron 1
sequences predicted to form RNA G-quadruplexes are highlighted in grey. Microwalk direction is shown by grey arrows; winner oligos are highlighted in
black. A box denotes a single nucleotide polymorphism reported previously (20). (B) Intron retention levels of each microwalk SSO in two cell lines. Error
bars denote SDs obtained from two independent cotransfections with reporter IC D-F.
structure predictions of overlapping intronic segments us-
ing Mfold suggested that the pre-mRNA forms stable lo-
cal stem-loops; one of them was further stabilized by a
G→C mutation (termed G2; Figure 5D, lower panel) that
increased intron 1 retention (7). Another G→C substitu-
tion (termed G3) located further downstream and destabi-
lizing the quadruplex structure (Figure 5D, upper panel)
also repressed intron splicing (7). Finally, CD2 oligonu-
cleotides containing either A or G at a single-nucleotide
polymorphism (Figure 4A and (20) exhibited very similar
CD spectra with well-defined melting transitions and Tm
values (data not shown), suggesting that the G and A al-
leles form the same structure.
To test further the importance of a tentative equilibrium
between canonical and noncanonical structures in intron
splicing, we used a combination ofCD,NMRandmutagen-
esis experiments (Figure 6). We synthesized an oligoribonu-
cleotide CD3 encompassing the 5′ end of the intron reten-
tion target and predicted stem-loops/quadruplex (Figures
4A and 6A). We also synthesised a mutated version CD4,
which carried two C→U transitions destabilizing the hair-
pin but maintaining stability of the quadruplex. The same
mutation was also introduced in our IC reporter construct
transfected into HEK293 cells.
The NMR spectrum of CD3 revealed the co-existence of
signals for both G-tetrad and canonical base-paired hair-
pin structures (termed H1 and H2) in equilibrium (Figure
6B and C). We investigated the effects of Mg2+ on the con-
formational equilibrium between quadruplex and hairpin
by adding 2 mM and then 6 mM MgCl2 to the buffered
solution containing 100 mM KCl. As reported by Bugaut
et al. (45), the conformational equilibrium was not sig-
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Figure 5. Biophysical characterization of RNA secondary structure formation. (A) Far-UV CD spectrum at 25◦C for CD1 (19-mer) and CD2 (20-mer)
RNAs, revealing ellipticity maximum at 265 and 270 nm, respectively. (B) 1H NMR spectra of CD1 and CD2 recorded at 800 MHz and 298 K showing
characteristic groups of resonances from H-bonded G bases. (C) Sigmoidal CD melting curves for the two RNAs showing a transition mid-point at 56.8
± 0.2◦C and 69.0 ± 0.45◦C, respectively. The two curves have been displaced slightly from each other for clarity. (D) The proposed parallel quadruplex
structure with two stackedG-tetrads connected by short loop sequences for CD1 (top panel). Predicted hairpin structures for CD2 are shown at the bottom
panel. G→C mutations are in red.
nificantly perturbed by the addition of Mg2+ in the pres-
ence of KCl. Thus, we observed formation of the RNA
hairpin and quadruplex structures in an environment that
mimics the cellular context where both K+ and Mg2+ ions
were present at high concentrations. The CD melting curve
showed a broad transition (Tm = 79.9◦C), consistent with
multiple conformational states with different stabilities. The
CC→UUmutation in CD4 resulted in the loss of NMR sig-
nals for H1 (Figure 6B) and a reduction in the Tm by 13oC,
consistent with the selective destabilization of the more sta-
ble hairpin H1, leading to an increase in the population of
H2 in equilibrium with the quadruplex. Transient transfec-
tions showed that the CC→UU mutation improved intron
1 splicing while a mutation termed M1 predicted to desta-
bilize both the quadruplex and the hairpin had only a small
effect (Figure 6D, Supplementary Table S2).
To explore how the equilibrium of these structures af-
fects intron splicing more systematically, we prepared a se-
ries ofmutated constructs to destabilize/maintain predicted
quadruplex, H1/H2 structures and two cytosine runs (Sup-
plementary Table S2). Their transcripts showed significant
differences in intron retention levels (Figure 7; P = 0.0001,
Kruskal–Wallis one-way ANOVA on ranks). First, elimi-
nation of the G-quadruplex increased intron 1 retention,
which was further enhanced by removing each cytosine run
(cf. mutations 4–6 with the wild-type, P = 0.0004). These
mutations appeared to have additive effects on intron reten-
tion (cf. wild-type versus mutations 1 or 9; 3 versus 2 and 4
versus 5). Second, the increased intron retention in the ab-
sence of the G-quadruplex was not altered by removing H1
and H2, but their elimination enhanced exon skipping (cf.
isoform 2 for mutations 4 versus 6). Third, when only one
of the two C4 runs was present, removal of H1 somewhat
improved intron 1 splicing (cf. 8 versus 9), consistent with
a statistically significant correlation between intron reten-
tion and predicted stability of testedRNAs (Figure 7B). The
efficiency of intron splicing was thus controlled by confor-
mational transitions between canonical and noncanonical
structures in equilibrium.
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Figure 6. Conformational quadruplex/hairpin transitions involving the antisense target. (A) Schematic equilibrium between hairpin (black) and quadru-
plex (dark blue) structures proposed to form within the G-rich motif encompassing oligoribonucleotide CD3. CD4 contains a CC→UUmutation (in red).
(B) The NMR spectrum in the 9–15 ppm region reveals imino proton signals corresponding to hydrogen bonded bases. The signals between 10 and 12
ppm are characteristic of Hoogsteen hydrogen bonded Gs within a G-tetrad (red box), while signals > 12 ppm are indicative of Watson–Crick A-U and
G-C base pairs within hairpin structures (black box). In CD3, hairpin H1 is significantly populated, but mutations in CD4 destabilize H1 making H2 the
major species, with both in equilibrium with the quadruplex structure. (C) Mfold predictions of two possible hairpins, consistent with the NMR data. (D)
Reduction of intron retention upon destabilization of the hairpin structure by the CC→UU mutation. Error bars denote SD of a duplicate experiment
with reporter IC D-C. Del5, the IC D-C reporter lacking segment del5 (Figure 1A); M1, a reporter containing two substitutions (Supplementary Table S2)
to destabilize both the G-quadruplex and the stem-loop.
Protein–RNA interactions in the region targeted by winner
SSOs
To identify proteins that interact with RNAs encompassing
the antisense target and/or associated canonical and non-
canonical structures, we carried out pull-down assays using
wild type and del5 RNAs transcribed from T7-tagged PCR
products, a syntheticRNA (CD5) representing the target se-
quence, and a control oligo containing a 3′ss CAG, termed
AV3. Western blotting showed that both wild type and del5
transcripts bound hnRNPs F/H but this binding was ab-
sent for CD5 (Figure 7C). These proteins were also detected
byMS/MSanalysis of differentially stained fragments from
pull down gels with wild type and del5 RNAs as compared
to beads-only controls (data not shown). Two antibodies
against SRSF2, which showed the highest score for putative
binding activity among several SR proteins (Supplementary
Figure S2), failed to detect any specific interaction (Figure
7C). Although the signal from hnRNP E1/E2, which con-
stitute a major poly(C) binding activity in mammalian cells
(46), was above background for del5 (Figure 7C), we ob-
served no change in intron retention in cells lacking hnRNP
E1/E2 (data not shown).
Splicing pattern ofG-rich andG-poor reporters uponDHX36
depletion
RNAG-quadruplexes bind helicaseDHX36, which is capa-
ble of converting quadruplex RNA to a stable duplex and
is a major source of quadruplex-resolving activity in HeLa
cells (26,47). DHX36 was crosslinked to an intronic splic-
ing enhancer in the ATM pre-mRNA (48) and could un-
wind the quadruplex structure within the 5′ region ofTERC
(26). To test if DHX36 depletion can influence INS splicing,
we transiently transfected G-quadruplex-poor and -rich re-
porters (Figure 8A, Table 1) into depleted cells. Control
constructs were chosen to give approximately equal repre-
sentation of spliced products, which was achieved by weak-
ening the branch site (24), thus providing a sensitive ex
vivo splicing assay. However, despite efficient DHX36 de-
pletion (Figure 8B), we did not see statistically significant
alterations of INS intron 1 retention in either short or long
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Figure 7. Identification of proteins that interact with pre-mRNAs encom-
passing the antisense target for intron retention. (A) Intron retention levels
for wild type andmutated reporter constructs (ICD-C) following transient
transfections into HEK293T cells. Mutations are shown in Supplementary
Table S2. RNA products are to the right. The presence of predicted RNA
quadruplexes, hairpins H1/H2 and the upstream and downstream C4 run
are indicated below the gel figure. Error bars denote SDs obtained from
two replicate experiments. (B) Intron retention levels of testedRNAs corre-
late with their predicted stabilities across the antisense target. (C) Western
blot analysis of a pull-down assay with antibodies indicated to the right.
NE, nuclear extracts; B, beads-only control; AV3, control RNA oligo con-
taining a cytosine run and a 3′ss AG (7). The sequence of CD5 RNA is
shown in Figure 4A.
constructs, nor did we observe major changes in G-poor
and G-rich controls (Figure 8C–E and data not shown).
These results are in agreement with a previous lack of sig-
nificant enrichment of quadruplex sequences among tran-
scripts downregulated in DHX36-depleted cells (49) and
with the absence of ATM response to the knockdown (48).
SSO-induced repression of a population-specific cryptic 5′
splice site of INS intron 1
In addition to rs689, INS intron 1 splicing is influenced by
a polymorphic TTGC insertion at rs3842740 located in the
vicinity of the natural 5′ss (21). This insertion is present in
a quarter of all African chromosomes but is absent on Cau-
casian IC haplotypes (20). The insertion activates a down-
stream cryptic 5′ss (Figure 1A), extending the 5′UTR of the
resulting mRNAs by further 26 nucleotides and repressing
Figure 8. Splicing pattern of quadruplex-rich and -poor minigenes upon
DHX36 depletion. (A) Schematics of reporter constructs. Predicted
quadruplexes are denoted by black rectangles; their densities are shown
in Table 1. Exons (boxes) are numbered; forward slash denotes shorten-
ing of F9 intron 3 (24). The F9 and TSC2minigenes contain branch point
substitutions c.253–25C and c.5069–18C, respectively, that impair splicing
(24). Cr5′ss-104; cryptic 5′ss 104 upstream of authentic 5′ss of intron 2.
(B) Immunoblot with antibodies against DHX36. sc, scrambled siRNA;
c, untreated cells. Error bars are SDs of two transfection experiments. (C–
E) Intron retention and exon skipping of the indicated reporters. The final
concentration of DHX36 siRNA was 50 nM. RNA products are shown
schematically to the right. Error bars are SDs of two transfection experi-
ments.
proinsulin expression (7,21). To test if the new 5′ss can be
efficiently inhibited by SSOs, we introduced the same in-
sertion in our IC construct and co-expressed the wild type
and mutated reporters with a bridging oligoribonucleotide
termed SSO10. Although the cryptic splicing was inhibited,
canonical splicing of intron 1 was not completely restored
even at high SSO10 concentrations (Supplementary Figure
S3 and data not shown), most likely as a result of subopti-
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Table 1. Density of predicted RNA G-quadruplexes in reporter constructs
Reporter TSC2 F9 INS
G-quadruplexes per nucleotidea 0.25 0.05 0.27
G score per nucleotidea 0.20 0.04 0.22
aThe length of non-overlapping quadruplex sequences and their G scores were computed as described (50).
mal recognition of the authentic 5′ss weakened by the inser-
tion.
To gain initial insights into folding of 5′UTR sequences
in the presence and absence of the insertion, we carried out
enzymatic structural probing using partial RNA digestion
with single- and double-strand specific RNAses (Supple-
mentary Figure S4). The overall cleavage positions and in-
tensities detected for the wild-type RNA were broadly con-
sistent with mfold predictions, in which two major stem-
loop regions (SL1 and SL2) were interrupted by several in-
ternal bulges. Both the structural probing and mfold pre-
dictions suggested that the insertion at rs3842740 extended
the central bulge in SL1 as the number of T1 and S1 cleav-
ages in this region increased in contrast to the remaining
portions of SL1 and in SL2 (Supplementary Figure S5). Fi-
nally, transcripts were not digested by RNase V1 in regions
showing quadruplex formation in vitro.
DISCUSSION
Antisense intron retention target in a splicing silencer of INS
intron 1
Here we demonstrate the first use of antisense technology
to reduce retention of the entire intron inmature transcripts
and to modify the haplotype-dependent INS expression us-
ing SSOs. Identification of winner SSOs that compensate
the adverse impact of the A allele at rs689 on efficient RNA
processing was facilitated by systematic mutagenesis of in-
tron 1 (7), and by our macro- (Figure 1) and micro-walk
(Figure 4) strategies. A similar approach was used previ-
ously for fine-mapping sequences that influence inclusion of
SMN2 exon 7 in themRNA (51). Interestingly, the target se-
quence contains a tandem CAG(G/C) motif, which resem-
bles a 3′ss consensus (Figure 4). Such ‘pseudo-acceptors’
were previously implicated in splice-site repression experi-
mentally (27) and are overrepresented in splicing silencers.
For example, the two tetramers are more common among
high-confidence 102 intronic splicing silencers (52) and are
depleted in 109 enhancers (53) identified by fluorescence ac-
tivated screen of random 10-mers. The YAG motifs were
also more frequent than expected among QUEPASA splic-
ing silencers (54), suggesting that they are important func-
tional components of the retention target. The intervening
cytosine tract may also play an important role as the fre-
quency of C4 runs among QUEPASA silencers is ∼2 times
higher than expected. We also found these motifs in 4% of
intronic splicing regulatory elements identified by a system-
atic screening of sequences inserted at positions –62/–51 rel-
ative to a tested 3′ss (55). This study identified an element
termed ISS22 (AAATAGAGGCCCCAG) that shared a 3′
nonamer (underlined) with the optimal intron retention tar-
get.However, unlike an optimal 3′ss recognition sequence of
AV3, our pull-down assay coupled with western blotting re-
vealed only a very weak binding if any to U2AF65 (Figure
7C).
Conformational transition between quadruplex and hairpins
in RNA processing control
The antisense target was identified just upstream of a po-
tential G-quadruplex forming RNA whose structure was
subsequently confirmed by CD and NMR analysis (Fig-
ures 1A and 5). RNA quadruplexes are more stable than
their DNA counterparts, have been increasingly implicated
in regulation of RNA metabolism (34–35,42–43) and offer
unique avenues for drug development (56). The 2-quartet
quadruplexes are thermodynamically less stable than their
3- or 4-quartet counterparts and are probably kinetically
more labile, yet they still display pronounced stability and
may serve asmore compliant and dynamic switches between
quadruplex and non-quadruplex structures in response to
cellular environment (57–59). The winner SSOs may block
interactions with trans-acting factors, alter higher-order
structures, the rate of RNA–protein complex formation
or impair conformational transition between the 2-quartet
quadruplex and H1/H2 (Figure 5). A similar transition has
been recently described for a quadruplex not predicted ab
initio (45), raising a possibility that additional sequences in
the G-rich intron 1 may participate in the equilibria near
the antisense target, possibly involving multiple quadruplex
motifs and competing stem-loops.
Our binding (Figure 7C) and functional experiments
showing the increased intron 1 retention upon hnRNP F/H
depletion and the opposite effect upon hnRNP F/H over-
expression (7) indicate that these proteins interact with key
splicing auxiliary sequences in this intron. In contrast to a
previous report concluding that hnRNP F binds directly to
the RNA quadruplex (60), hnRNP F has been shown to
prevent formation of RNA quadruplexes by binding exclu-
sively single-stranded G-tracts (61). Although preliminary
predictions based on primate genomes suggest that the ma-
jority of putative quadruplexes are likely to fold into canon-
ical structures (62), future studies will be required to explain
how decreased pre-mRNA occupancy by these proteins,
presumably promoting quadruplex formation (61), can re-
duce splicing efficiency.
RNA quadruplexes in coupled splicing and translational gene
expression control
RNA quadruplexes were predicted in ∼8.0% of 5′UTR
and were proposed to act as general inhibitors of transla-
tion (62,63). INS intron 1 is weakly spliced and U2AF35-
dependent (7) and a significant fraction of intron 1-
containing transcripts is exported from the nucleus (23).
This suggests that the RNA G-quadruplex formed by CD1
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could influence translation of these mRNAs, which contain
a three-amino acid uORF specific for Homininae (7). This
uORF markedly inhibits proinsulin expression and is lo-
cated just a few base-pairs downstream, prompting a spec-
ulation that the G-quadruplexes can promote translation
by sequestering uORFs. As functional 2-quartet quadru-
plexes are required for activity of internal ribosomal entry
sites (57), future studies should also explore the importance
of these structures in cap-independent translation of proin-
sulin transcripts (64).
Antisense strategies for dependencies in splice-site selection
Apart from canonical mRNA isoform 4, isoforms 2, 3
and 6 (Figure 1B) have been found in expressed sequence
tag databases derived from cDNA libraries from insulin-
producing tissues (21). This suggests that cryptic splice sites
produced by our reporter construct are recognized in vivo
and that our haplotype-dependent reporter system reca-
pitulates these events accurately in cultured cells no mat-
ter whether the cells express or not endogenous insulin.
Apart from repressing intron 1-retaining transcripts, opti-
mal SSOs increased utilization of cryptic 3′ss of exon 3 (Fig-
ure 2). This undesired effect could be explained by coor-
dination of splicing of adjacent exons and introns, which
was observed previously for individual genes and globally
(65–69). Also, G-richness downstream transcription start
sites have been associated with RNA polymerase II paus-
ing sites (70). Although the two robustly competing 3′ss of
intron 2 are likely to respond to non-specific signals that in-
fluence RNA folding (Figure 3, Supplementary Table S1),
it might be possible to alleviate the observed dependencies
and reduce cryptic 3′ss activation using SSO combinations
at linked splice sites and examine their synergisms or antag-
onisms, benefiting from the use of full-gene constructs as
opposed to minigenes.
Multifunctional antisense oligonucleotides to reduce INS in-
tron 1 retention
Since the first use of 2′-O-methyl-phosphorothioate SSOs
(71), this type of chemical modification has been success-
fully exploited for many in vitro and in vivo applications (9–
10,72). To further fine-tune expression of mRNA isoforms,
optimized SSOs can be designed to tether suitable trans-
acting splicing factors to their target sequences (11,73). An
obvious candidate for our system isU2AF35 because intron
1 is weak as a result of relaxation of the 3′ss in higher pri-
mates and is further undermined by the A allele at rs689,
which renders this intron highly U2AF35-dependent (Fig-
ure 3) (7). Apart from U2AF35, future bi- or multifunc-
tional antisense strategies can employ binding platforms for
splicing factors previously shown to influence INS intron 1
and exon 2 splicing, such as Tra2 or SRSF3 (7). Tra2 is
likely to bind the SSO6 target which forms a predicted stable
hairpin structure with a potent GAA splicing enhancer in a
terminal loop (Figure 3B). SRSF3 is required for repression
of the cryptic 3′ss of intron 2 (7) and binds pyrimidine-rich
sequence with a consensus (A/U)C(A/U)(A/U)C (74). The
CAUC motif, which interacts with the RNA-recognition
motif of SRSF3 (75), is present just upstream of the cryptic
3′ss.
Normalizing intron retention levels in human genetic disease
Our results provide an opportunity to use non-genetic
means to compensate less efficient splicing and lower INS
expression from haplotypes predisposing to type 1 diabetes.
Common variants such as rs689 contribute to a great ex-
tent to the heritability of complex traits, including autoim-
mune diseases (76), but their functional and structural con-
sequences are largely unknown. If optimized INS SSOs can
be safely and efficiently introduced into the developing thy-
mus, this approach may offer a novel preventive approach
to promote tolerance to the principal self-antigen in type
1 diabetes. The most obvious candidates for such interven-
tion are mothers who had an affected child homozygous
for disease-predisposing alleles at both HLA and INS loci.
Such genotypes were associated with an extremely high dis-
ease risk for siblings (77). Apart from primary prevention
of type 1 diabetes, future SSO-based therapeutics might be
applicable to patients with significant residual -cell activ-
ity at diagnosis and to those who are eligible to receive
-cell transplants and may benefit from increased intron-
mediated enhancement of proinsulin expression from trans-
planted cells. It is also possible to envisage use of this ther-
apeutic modality for other patients with diabetes through a
more dramatic enhancement of intron splicing and proin-
sulin expression by targeting multiple splicing regulatory
motifs with multifunctional SSOs. Future studies should
therefore examine utility of our SSOs in thymic epithelial
cells and -cells that may provide a more natural system for
testing their impact on both exo- and endogenous proin-
sulin expression. Finally, similar antisense strategies may
help reduce pervasive intron retention in cancer cells result-
ing from somatic mutations of splicing factor genes, as il-
lustrated by specific substitutions in the zinc finger domain
of U2AF35 in myeloproliferative diseases (78).
SUPPLEMENTARY MATERIAL
Supplementary Data are available Online.
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